The role of angiotensin I-converting enzyme gene polymorphism in renal disease

Current Opinion in Nephrology and Hypertension

Volumn 5, Issue 6, 1996, Pages 552-555

  Schmidt, Susanne ^a,b   Ritz, Eberhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Dept of Int Medicine/Renal Unit ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

DIABETIC NEPHROPATHY; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; GLOMERULUS FILTRATION RATE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DISEASE; PRIORITY JOURNAL; REVIEW;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DISEASE PROGRESSION; HUMANS; KIDNEY DISEASES; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 0030481010     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199611000-00016     Document Type: Review

References (26)

1. Rigat B, Hubert C, Alhenc-Gélas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion-polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86:1343-1346.
2. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F: Evidence from combined segregation and linkage analysis, that a variant in the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992, 51:197-205.
3. Costerousse O, Allegrini J, Lopes M, Alhenc-Gélas F: Angiotensin I converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993, 290:33-40.
4. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel J-M: Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nature Genet 1992, 1:72-75.
5. Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol P, Fraser R, Foy CJW, Watt GCM: The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 1993, 21:455-460.
6. Cambien F, Poirier O, Lecerf L, Evans A, Cambou J-P, Arveiler D, Luc G, Bard J-M, Bara L, Ricard S et al.: Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature 1992, 359:641-644.
7. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, Taft CS, Perryman MB: Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993, 342:1073-1075.
8. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene T-T, Hallab M, Cambien F, Passa P, Alhenc-Gélas F: Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994, 43:384-388.
9. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Parving H-H: Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy in IDDM patients. Diabetes 1995, 44:489-494.
10. Schmidt S, Schöne N, Ritz E, and the Diabetic Nephropathy Study Group: Association of ACE gene polymorphism and diabetic nephropathy. Kidney Int 1995, 47:1176-1181. This study failed to show an association between the IID polymorphism of the ACE gene and the presence of diabetic nephropathy.
11. Dudley CRK, Keavney B, Stratton IM, Turner RC, Ratcliff PJ: UK Prospective Diabetes, Study XV. Relationship of renin-angiotensin system gene polymorphism with microalbuminuria in NIDDM. Kidney Int 1995, 48:1907-1911. This paper shows that the ACE gene polymorphism is not associated with the manifestation of diabetic nephropathy, but determines the severity of diabetic nephropathy.
12. Fujisawa T, Ikegami H, Shen G-Q, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, Ueda H, Rakugi H, Higaki J et al.: Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 1995, 18:983-985.
13. Mizuiri S, Hemmi H, Inoue A, Yoshikawa H, Tanegashima M, Fushimi T, Ishigami M, Amagasaki Y, Ohara T, Shimatake H, Hasegawa A: Angiotensin-converting enzyme polymorphsim and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 1995, 70:455-459.
14. Doi Y, Yoshizumi H, Yoshinari M, Iino K, Yamamoto M, Ichikawa K, Iwase M, Fujishima M: Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 1996, 39:97-102.
15. Jacobsen P, Tarnow L, Rossing P, Cambien F, Lecerf L, Poirier O, Parving H-H: The insertion/deletion (I/D) polymorphism in the angiotensin I-converting enzyme (ACE) gene predicts the progression of diabetic nephropathy during ACE inhibition (ACEI) in insulin dependent diabetic (IDDM) patients [Abstract]. J Am Soc Nephrol 1995, 6:450.
16. Schmidt S, Stier E, Hartung R, Stein G, Bahnisch J, Woodroffe AJ, Clarkson AR, Ponticelli C, Campise M, Mayer G et al: No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis. Am J Kidney Dis 1995, 5:727-737.
17. Schmidt A, Kiener HP, Barnas U, Arias I, Illievich A, Auinger M, Graninger W, Kaider A, Mayer G: Angiotensin-converting enzyme polymorphism in patients with terminal renal failure. J Am Soc Nephrol 1996, 7:314-317.
18. Hunley TE, Julian BA, Phillips JA, Summar ML, Yoshida H, Horn RG, Brown NJ, Fogo A, Ichikawa I, Kon V: Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 1996, 49:571-577.
19. Harden PN, Geddes C, Rowe PA, McIlroy JH, Boulton-Jones M, Rodger RSC, Junor BJR, Briggs JD, Connell JMC, Jardine AG: Polymorphism in the angiotensin-converting enzyme gene and progression of IgA nephropathy. Lancet 1995, 345:1540-1542. This is the first paper to show an association between the D allele of the ACE gene polymorphism and the progression of IgA glomerulonephritis.
20. Yoshida H, Mitarai T, Kawamura T, Kitajima T, Miyazaki Y, Nagasawa R, Kawaguchi Y, Kubo H, Ichikawa I, Sakai O: Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic respnsiveness of IgA nephropathy. J Clin Invest 1995, 96:2162-2169. This paper describes the relationship between the ACE gene polymorphism and progression of IgA glomerulonephritis as well as susceptibility to treatment with ACE inhibitors.
21. Moriyama T, Kitamura H, Ochi S, Izumi M, Yokoyama K, Yamauchi A, Ueda N, Kamada T, Imai E: Association of angiotensin I-converting enzyme gene polymorphism with susceptibility to antiproteinuric effect of angiotensin I- converting enzyme inhibitors in patients with proteinuria. J Am Soc Nephrol 1995, 6:1674-1678.
22. van Essen GG, Rensma PL, de Zeeuw D, Sluiter WJ, Scheffer H, Apperloo AJ, de Jong PE: Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet 1996, 347:94-95. This paper shows the association between the IID polymorphism and the decline in renal function, but no evidence for an association with susceptability to treatment is reported.
23. Apperloo AJ, de Zeeuw D, de Jong PE: Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non diabetic renal disease. Kidney Int 1994, 45(suppl45):S174-S178.
24. Rossing P, Hommel E, Smidt UM, Parving H-H: Reduction in albuminuria predicts diminished progression in diabetic nephropathy. Kidney Int 1994; 45(suppl 45):S145-S149.
25. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Ricard S, Poirier O, Parving H-H: Angiotensinogen gene polymorphism in IDDM patients with diabetic nephropathy. Diabetes 1996, 45:367-369.
26. McLaughlin KJ, Jagger C, Small M, Jardine AG: Effect of angiotensinogen gene T235 variant on the development of diabetic complications in type II diabetes mellitus [Letter]. Lancet 1995, 346:1160.